Detalles de la búsqueda
1.
Palivizumab in the prevention of severe respiratory syncytial virus infection in children with congenital heart disease; a novel cost-utility modeling study reflecting evidence-based clinical pathways in Spain.
Health Econ Rev
; 7(1): 47, 2017 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29260345
Resultados
1 -
1
de 1
1
Próxima >
>>